Inventor · disambiguated record
Jason Zbieg
Also filed as: ZBIEG JASON · ZBIEG JASON R · ZBIEG JASON ROBERT
12 granted patents·16 pending applications·31 citations·filing 2015–2025
85Inventor score
Top patents by PatentIndex Score
28 records- 0197US9980947B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted May 29, 2018·17 cites·87 claims
- 0292US10966963B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2018·Granted Apr 6, 2021·10 cites·32 claims
- 0390US11787775B2Therapeutic compounds and methods of useGENENTECH INC·Filed 2021·Granted Oct 17, 2023·2 cites·27 claims
- 0486US2025114338A1TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOFGENENTECH INC·Filed 2024·Application pending·0 cites
- 0583US10654867B2Heteroaryl estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2019·Granted May 19, 2020·1 cites·5 claims
- 0676US12435054B2Therapeutic compounds and methods of useGENENTECH INC·Filed 2023·Granted Oct 7, 2025·0 cites·19 claims
- 0773US2025074881A1Therapeutic compounds and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 0872US12233052B2Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2021·Granted Feb 25, 2025·0 cites·32 claims
- 0970US2025230147A1Lactams as cbl-b inhibitorsGENENTECH INC·Filed 2024·Application pending·0 cites
- 1069US10399939B2Tetrahydronaphthalene estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Sep 3, 2019·1 cites·35 claims
- 1168US12110276B2Pyrazolo compounds and methods of use thereofGENENTECH INC·Filed 2022·Granted Oct 8, 2024·0 cites·28 claims
- 1268US2025122171A1Substituted Amine Compounds, Compositions and Methods of UseDEEP APPLE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1367US12275745B2Therapeutic compounds and methods of useGENENTECH INC·Filed 2022·Granted Apr 15, 2025·0 cites·20 claims
- 1460US2023079990A1Lactams as cbl-b inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1559US2023242506A1Heterobifunctional molecules as tead inhibitorsGENENTECHT INC·Filed 2022·Application pending·0 cites
- 1658US2025171464A1Therapeutic compounds and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 1758US2023002396A1Therapeutic compoundsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1857US12187709B2Lactams as CBL-B inhibitors selective over C-CBLGENENTECH INC·Filed 2022·Granted Jan 7, 2025·0 cites·20 claims
- 1956US2018002344A1Heteroaryl estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 2053US2022281819A1Therapeutic compounds and methods of useGENENTECH INC·Filed 2022·Application pending·0 cites
- 2152US2021188775A1Carboxamide and sulfonamide derivatives useful as tead modulatorsGENENTECH INC·Filed 2021·Application pending·0 cites
- 2252US2019152970A1TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOFGENENTECH INC·Filed 2019·Application pending·0 cites
- 2352US2024300927A1Amides as cbl-b inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 2451US2021238184A1Therapeutic compoundsGENENTECH INC·Filed 2020·Application pending·0 cites
- 2548US2017362228A1TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOFGENENTECH INC·Filed 2017·Application pending·0 cites
- 2643US11008312B2Pyridazine derivatives as RORc modulatorsGENENTECH INC·Filed 2019·Granted May 18, 2021·0 cites·9 claims
- 2739US9969732B2Tetrahydroisoquinoline estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2017·Granted May 15, 2018·0 cites·33 claims
- 2837US2016175284A1Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason Zbieg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →